Overcoming platinum resistance in ovarian cancer by targeting pregnancy-associated plasma protein-A

OBJECTIVES: Inhibition of pregnancy-associated plasma protein-A (PAPP-A), an upstream activator of the insulin-like growth factor (IGF) pathway, is known to augment sensitivity to platinum-based chemotherapy. This study further tests the efficacy of PAPP-A inhibition with a monoclonal antibody inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Torres, Diogo, Hou, Xiaonan, Bale, Laurie, Heinzen, Ethan P., Maurer, Matthew J., Zanfagnin, Valentina, Oberg, Ann L., Conover, Cheryl, Weroha, S. John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872139/
https://www.ncbi.nlm.nih.gov/pubmed/31751381
http://dx.doi.org/10.1371/journal.pone.0224564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872139/
https://www.ncbi.nlm.nih.gov/pubmed/31751381
http://dx.doi.org/10.1371/journal.pone.0224564

Ejemplares similares